SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors interpret a recent SEC filing regarding executive change-of-control agreements as a strategic precursor to an imminent buyout. This momentum is further fueled by a high-pressure environment for short sellers, with the community actively monitoring record-high borrow fees and constrained share availability ahead of a pivotal data readout.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor scrutiny and selling pressure as concerns mount over its massive capital expenditure on AI infrastructure and a perceived lack of immediate return on investment. The community is sharply divided, with some viewing the technical breakdown and lower valuation as a generational buying opportunity, while others express frustration over the stock's persistent underperformance compared to the broader market and chip-focused sectors.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing significant volatility as investors debate the impact of rising memory chip costs on profit margins following recent price increases across its iPad and Mac lineups. The community is actively split between those viewing the pullback as a buying opportunity for a resilient market leader and others expressing concern that these price hikes signal structural demand destruction and the end of the stock's recent momentum.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing significant market volatility as investors weigh a blowout earnings report and massive analyst price target upgrades against broader sector concerns regarding hyperscaler capital spending and cost-push inflation. The community is sharply divided, with some traders actively capitalizing on the rapid price swings through high-conviction momentum plays, while others express caution, viewing the recent activity as a potential bubble or an overextended cycle.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing extreme volatility and heavy volume as community members debate whether the stock is a prime candidate for a short squeeze or a fundamental turnaround play. While many retail investors are actively buying the dip to apply pressure on short sellers, others remain skeptical about the sustainability of the recent momentum.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as shareholders react to its aggressive leveraged Bitcoin accumulation strategy amidst a broader crypto market downturn. Investors remain sharply divided between those viewing the current price as a generational buying opportunity and critics who argue the company's reliance on capital raises and debt could trigger a prolonged deleveraging spiral.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the company restores NBCUniversal content to its platform, a development community members hope will drive subscriber growth ahead of major upcoming sporting events. Despite this catalyst, investors remain deeply divided, with many expressing long-standing frustration over management's track record and the stock's significant decline, while bulls point to the Disney partnership and recent carriage deals as signs of a potential turnaround.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh the potential for increased engagement and handle driven by the ongoing FIFA World Cup and prediction market expansion against broader market volatility that has pressured the share price. The community is heavily divided, with active debates between bulls highlighting institutional support and long-term upside optionality, and vocal skeptics focusing on management's share sales and consistent underperformance compared to tech-sector growth.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following a strong quarterly earnings report that featured a revenue beat and upward guidance, fueling investor optimism despite ongoing community debate regarding long-term post-TDAPA reimbursement projections. Discussions remain centered on the company's product adoption, active share buyback program, and the potential impact of pending kidney care legislation on future growth.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is experiencing significant volatility as market participants debate whether recent price pullbacks represent a long-term structural correction or a buying opportunity driven by persistent industrial demand for AI infrastructure. The community remains deeply divided, with some investors aggressively accumulating physical holdings on the belief that silver's critical role in technology and energy will drive future gains, while others caution against ongoing liquidation pressure and market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CMMB  
 
It is clear that the CEO’s share purchase was a tactical move to absorb the impact of the two board resignations, aiming to stabilize the stock and prevent sharp volatility that usually follows such news. 
 
However, this purchase was ultimately unsuccessful, because the market was anticipating a partnership or acquisition announcement instead. As I mentioned before, symbolic insider buying sends the opposite signal: confidence, but no imminent catalyst. 
 
The positive takeaway remains that management is attentive to the share price and investor sentiment, even if the timing of the move did not align with market expectations

StockTwits Web

Chemomab Therapeutics Ltd - ADR

  
 
It is clear that the CEO’s share purchase was a tactical move to absorb the impact of the two board resignations, aiming to stabilize the stock and prevent sharp volatility that usually follows such news. 
 
However, this purchase was ultimately unsuccessful, because the market was anticipating a partnership or acquisition announcement instead. As I mentioned before, symbolic insider buying sends the opposite signal: confidence, but no imminent catalyst. 
 
The positive takeaway remains that management is attentive to the share price and investor sentiment, even if the timing of the move did not align with market expectations

الصابر العنزي

@Zdxss1 -Appreciate the opinion but nobody has any idea of the motive here. She could simply be acquiring shares at what she feels is a discount price. You characterize it as symbolic but you do not k ow her financial situation. It is all speculation on your part. The bottom line is this is a ridiculously undervalued asset and in time investors are betting it rerates to a more realistic valuation.

Scott

StockTwits for iOS

 -Appreciate the opinion but nobody has any idea of the motive here. She could simply be acquiring shares at what she feels is a discount price. You characterize it as symbolic but you do not k ow her financial situation. It is all speculation on your part. The bottom line is this is a ridiculously undervalued asset and in time investors are betting it rerates to a more realistic valuation.

roger barnes

@cayman777  
 
I&#39;m not offering my personal opinion here; I&#39;m simply interpreting what the market is saying. 
 
The market, by its very nature, connects events and interprets them in this way. The current drug&#39;s value in clinical trials is the highest, unmatched by any other drug in terms of results and therapeutic prospects. 
 
Unfortunately, however, the market hasn&#39;t given it its due in terms of evaluation, as it&#39;s still being priced far below its scientific and regulatory value.

  
 
I'm not offering my personal opinion here; I'm simply interpreting what the market is saying. 
 
The market, by its very nature, connects events and interprets them in this way. The current drug's value in clinical trials is the highest, unmatched by any other drug in terms of results and therapeutic prospects. 
 
Unfortunately, however, the market hasn't given it its due in terms of evaluation, as it's still being priced far below its scientific and regulatory value.

@Zdxss1 -I cannot disagree with that assessment. Until cmmb produces a concrete partnership this is at the whims of mm/algos.

 -I cannot disagree with that assessment. Until cmmb produces a concrete partnership this is at the whims of mm/algos.